Exchange campaign coagulation measuring system
10.10.2016 13:10
Diagnostics manufacturer Alere INC is discontinuing the Alere "INRatio" and "INRatio2" PT/INR product line. According to their own statements, users should therefore switch to another system for coagulation measurement at the point of care as quickly as possible. Roche Diagnostics Deutschland GmbH offers users of these Alere devices the opportunity to switch cost-effectively to the Roche "CoaguChek" Pro II system. The new system has been on the German market since April 2016 for coagulation management in the practice laboratory and in the clinic. Practices and clinics now have the opportunity to switch to the Roche CoaguChek® Pro II system at a preferential price as part of an exchange campaign.
In a BfArM notification dated September 12, 2016, Alere San Diego INC informs that the company is voluntarily discontinuing the Alere INRatio/INRatio 2 PT/INR monitoring system from the market. The letter states: “Customers/patients who currently have one or more Alere INRatio®/INRatio® 2 PT/INR monitoring systems should consider switching to an alternative PT/INR testing method, such as a plasma-based INR laboratory method or a third-party point-of-care monitoring system, as quickly as possible.”
When replacing an Alere INRatio/INRatio II device, the new CoaguChek Pro II device including 6 large packs of test strips (“CoaguChek” PT Test 2 x 24) is available at an attractive special price of EUR 799 plus VAT (savings: EUR 825 net). Roche Diagnostics says it provides professional training on the “CoaguChek” Pro II system free of charge.
The often difficult process of taking blood via the vein, especially in older patients, is replaced by taking a small drop of blood (8µl) from the fingertip. The use of the “CoaguChek” Pro II system also makes INR/%Quick determination easier during home visits and in nursing homes, as the small device and test strips can easily be taken with you.
Patients who use the Alere device for coagulation self-management can also apply to their health insurance company to switch it to the proven “CoaguChek” XS patient system. Roche Diagnostics offers patients a free telephone introduction to the device.